Effect of reclassification of the IMDC model in patients with metastatic renal cell carcinoma treated with targeted therapy in the first-line and second-line settings
- Nobuyuki Tanaka
- , Ryuichi Mizuno
- , Suguru Shirotake
- , Keiichi Ito
- , Yota Yasumizu
- , Ayako Masunaga
- , Yujiro Ito
- , Yasumasa Miyazaki
- , Masayuki Hagiwara
- , Kent Kanao
- , Shuji Mikami
- , Ken Nakagawa
- , Tetsuo Momma
- , Takeshi Masuda
- , Tomohiko Asano
- , Masafumi Oyama
- , Mototsugu Oya
研究成果: ジャーナルへの寄稿 › 学術論文 › 査読
5
!!Link opens in a new tab
被引用数
(Scopus)